Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Endoscopic scoring systems in Crohn's disease and ulcerative colitis aim to translate the assessment of mucosal disease activity into a quantified value. This value seeks to provide a clear, objective record of the endoscopic mucosal severity, which can then be used to guide medical management decisions. The primary driver of all endoscopic indices, however, is to define a scale of responsiveness for therapeutic endpoints in clinical trials. Mucosal healing now has widespread acceptance as a therapeutic and clinical endpoint, but despite the development of multiple endoscopic scoring systems, the endoscopic definition has yet to be resolved. This review describes recent advances in endoscopic scoring systems for ulcerative colitis (Mayo Clinic endoscopy subscore, UCEIS, and UCCIS among others) and for Crohn's disease.

Original publication

DOI

10.1007/s11894-015-0470-0

Type

Journal article

Journal

Curr Gastroenterol Rep

Publication Date

12/2015

Volume

17

Keywords

Crohn’s disease, Endoscopy, Mayo score, UCEIS, Ulcerative colitis, Colitis, Ulcerative, Crohn Disease, Endoscopy, Gastrointestinal, Humans, Inflammatory Bowel Diseases, Observer Variation, Severity of Illness Index